DILO BM
CCI approves Corona Remedies-GlaxoSmithKline dealDilo-BM, Dilo-DX, Stelbid and Vitneurin brands of GlaxoSmithKline would be acquired by Corona Remedies along with trademark and goodwill.07 Mar, 2017, 11.13 PM IST
Load More
KPIT outlook shock sends IT stocks sliding as growth worries intensify
India's premium has almost entirely disappeared now: Ben Powell, BlackRock
Upstox's erroneous a/c freeze mail sparks client panic
Rupee logs sharpest fall since June 8, ends at 95.24 against dollar
Bloomberg global index entry in sight for Indian G-Secs
SP Group to issue Rs 25,500 crore bonds against Tata Sons stake
BJP rejects Mahua Moitra's 'egg attack' claim, blames TMC infighting
Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service